{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:41:04Z","timestamp":1791661264472,"version":"4.3.4"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Government of India Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bbrc.2026.153563","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T15:37:37Z","timestamp":1772984257000},"page":"153563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Decoding antibiotic resistance in tuberculosis: Role of RRDR and non-RRDR mutations in diagnostic perspectives"],"prefix":"10.1016","volume":"812","author":[{"given":"Risha","family":"Hazarika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjukta","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153563_bib1","unstructured":"Tuberculosis, (n.d.). https:\/\/www.who.int\/health-topics\/tuberculosis#tab=tab_1 (accessed May 4, 2025)."},{"key":"10.1016\/j.bbrc.2026.153563_bib3","unstructured":"INDIA TB REPORT 2024 NATIONAL TB ELIMINATION PROGRAMME, (n.d.). http:\/\/www.tbcindia.gov.in (accessed May 6, 2025)."},{"key":"10.1016\/j.bbrc.2026.153563_bib4","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1021\/acs.jmedchem.2c00227","article-title":"Tuberculosis drug discovery: challenges and new Horizons","volume":"65","author":"Fernandes","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.153563_bib2","unstructured":"Global Tuberculosis Report 2024, (n.d.). https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024 (accessed May 4, 2025)."},{"key":"10.1016\/j.bbrc.2026.153563_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in mycobacterium tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153563_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40506-016-0098-0","article-title":"New era of TB drug discovery and its impact on disease management","volume":"8","author":"Zheng","year":"2016","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib7","article-title":"Assessing physical and chemical properties of saliva among tuberculosis patients on anti-tuberculosis treatment - an observational study","volume":"28","author":"Gowdappa Doddawad","year":"2022","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib8","article-title":"BPaLM regimen against drug-resistant tuberculosis in India: a need of the hour","volume":"16","author":"Yadav","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bbrc.2026.153563_bib9","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/S2213-2600(23)00426-5","article-title":"Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis","volume":"12","author":"Labuda","year":"2024","journal-title":"Lancet Respir. Med."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2026.153563_bib10","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijid.2023.03.013","article-title":"Update of drug-resistant tuberculosis treatment guidelines: a turning point","volume":"130","author":"Vanino","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.37871\/jbres1542","article-title":"Drug-resistant tuberculosis types and their treatment regimens using first-line, second-line injectable, third-line, fluoroquinolones, aminoglycosides, cyclic polypeptides, novel and repurposed anti-tuberculosis drugs","volume":"3","author":"Mumena","year":"2022","journal-title":"J. Biomed. Res. Environ. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2026.153563_bib12","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijid.2022.03.026","article-title":"Drug resistant TB - latest developments in epidemiology, diagnostics and management","volume":"124","author":"Tiberi","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.12701\/yujm.2020.00626","article-title":"Diagnosis and treatment of multidrug-resistant tuberculosis","volume":"37","author":"Jang","year":"2020","journal-title":"Yeungnam Univ. J. Med."},{"key":"10.1016\/j.bbrc.2026.153563_bib14","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijid.2023.03.013","article-title":"Update of drug-resistant tuberculosis treatment guidelines: a turning point","volume":"130","author":"Vanino","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1159\/000539410","article-title":"Treatment of MDR, Pre-XDR, XDR, and rifampicin-resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany, and Switzerland","volume":"103","author":"Otto-Knapp","year":"2024","journal-title":"Respiration"},{"key":"10.1016\/j.bbrc.2026.153563_bib16","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1021\/acs.jmedchem.2c00227","article-title":"Tuberculosis drug discovery: challenges and new Horizons","volume":"65","author":"Fernandes","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.153563_bib17","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jac\/dkx506","article-title":"Evolution of drug resistance in mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care","volume":"73","author":"Dookie","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbrc.2026.153563_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijid.2020.11.007","article-title":"Variations in rifampicin and isoniazid resistance associated genetic mutations among drug na\u00efve and recurrence cases of pulmonary tuberculosis","volume":"103","author":"Kabir","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/aihb.aihb_15_24","article-title":"Rifampicin-resistant tuberculosis: a global health dilemma","volume":"14","author":"Ahmad","year":"2024","journal-title":"Adv. Human Biol."},{"key":"10.1016\/j.bbrc.2026.153563_bib20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jiph.2018.04.005","article-title":"Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis","volume":"11","author":"Zaw","year":"2018","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.bbrc.2026.153563_bib21","unstructured":"Global Tuberculosis Report 2024, (n.d.). https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024 (accessed November 24, 2025)."},{"key":"10.1016\/j.bbrc.2026.153563_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4314\/ahs.v22i2.18","article-title":"Prevalence of rifampicin resistant tuberculosis among pulmonary tuberculosis patients in Enugu, Nigeria","volume":"22","author":"Ulasi","year":"2022","journal-title":"Afr. Health Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153563_bib23","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1038\/s41467-023-41937-9","article-title":"Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis","volume":"14","author":"Menzies","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153563_bib24","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.2147\/IDR.S313717","article-title":"Rarity of rpoB mutations outside the rifampicin resistance-determining region of Mycobacterium tuberculosis isolates from patients responding poorly to first-line tuberculosis regimens in Beijing, China: a retrospective study","volume":"14","author":"Guo","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bbrc.2026.153563_bib25","article-title":"Compensatory mutations are associated with increased in vitro growth in resistant clinical samples of Mycobacterium tuberculosis","volume":"10","author":"Brunner","year":"2024","journal-title":"Microb. Genom."},{"key":"10.1016\/j.bbrc.2026.153563_bib26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/molecules27030885","article-title":"The structural basis of Mycobacterium tuberculosis RpoB drug-resistant clinical mutations on rifampicin drug binding","volume":"27","author":"Amusengeri","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153563_bib27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/22221751.2021.1908096","article-title":"Compensatory effects of M. tuberculosis rpoB mutations outside the rifampicin resistance-determining region","volume":"10","author":"Ma","year":"2021","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.bbrc.2026.153563_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2023.100399","article-title":"Molecular analysis of rpoB gene mutation in MTB detected isolates in a tertiary care centre (AGMC) of North-East, India","volume":"45","author":"Majumdar","year":"2023","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4314\/ejhs.v28i3.7","article-title":"Mutations of rpob gene associated with rifampin resistance among Mycobacterium tuberculosis isolated in tuberculosis regional reference laboratory in Northeast of Iran during 2015\u20132016","volume":"28","author":"Tavanaee Sani","year":"2018","journal-title":"Ethiop. J. Health Sci."},{"key":"10.1016\/j.bbrc.2026.153563_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmi.2016.09.006","article-title":"Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria","volume":"23","author":"Andre","year":"2017","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.bbrc.2026.153563_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jctube.2017.06.001","article-title":"Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates","volume":"8","author":"Muthaiah","year":"2017","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/mmi.13606","article-title":"Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis","volume":"103","author":"Molodtsov","year":"2017","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00483-25","article-title":"Rapid detection of rifampin resistance in Mycobacterium tuberculosis using nucleotide MALDI-TOF MS: a comparative study with phenotypic drug susceptibility testing and DNA sequencing","volume":"13","author":"Zhang","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2026.153563_bib34","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.2147\/IDR.S333433","article-title":"rpoB mutations and effects on rifampin resistance in Mycobacterium tuberculosis","volume":"14","author":"Li","year":"2021","journal-title":"Infect. Drug Resist"},{"key":"10.1016\/j.bbrc.2026.153563_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/tmi.14104","article-title":"Multi-drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam","volume":"30","author":"Nguyen","year":"2025","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.bbrc.2026.153563_bib36","article-title":"Novel and reported compensatory mutations in rpoABC genes found in drug resistant tuberculosis outbreaks","volume":"14","author":"Conkle-Gutierrez","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.612675","article-title":"Evolution of drug-resistant Mycobacterium tuberculosis strains and their adaptation to the human lung environment","volume":"12","author":"Allu\u00e9-Guardia","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib38","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1111\/febs.17142","article-title":"Actionable mechanisms of drug tolerance and resistance in Mycobacterium tuberculosis","volume":"291","author":"Datta","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2026.153563_bib39","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/jam.14478","article-title":"Recent updates on drug resistance in Mycobacterium tuberculosis","volume":"128","author":"Singh","year":"2020","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.1038","article-title":"Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes","volume":"44","author":"Comas","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2026.153563_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00164-18","article-title":"Source of the fitness defect in rifamycin-resistant Mycobacterium tuberculosis RNA polymerase and the mechanism of compensation by mutations in the \u03b2\u2032 subunit","volume":"62","author":"Stefan","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2026.153563_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/ijmy.ijmy_27_20","article-title":"Determination of potentially novel compensatory mutations in rpoC associated with rifampin resistance and rpoB mutations in Mycobacterium tuberculosis clinical isolates from Peru","volume":"9","author":"Vargas","year":"2020","journal-title":"Int. J. Mycobacteriol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153563_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-62946-8","article-title":"Large-scale statistical analysis of Mycobacterium tuberculosis genome sequences identifies compensatory mutations associated with multi-drug resistance","volume":"14","author":"Billows","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153563_bib44","article-title":"Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh","volume":"9","author":"Lempens","year":"2023","journal-title":"Microb. Genom."},{"key":"10.1016\/j.bbrc.2026.153563_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01324-23","article-title":"Insight into the drug-resistant characteristics and genetic diversity of multidrug-resistant Mycobacterium tuberculosis in China","volume":"11","author":"Song","year":"2023","journal-title":"Microbiol. Spectr"},{"key":"10.1016\/j.bbrc.2026.153563_bib46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12879-025-10655-6","article-title":"Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis","volume":"25","author":"Jose Vadakunnel","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3638-z","article-title":"Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis","volume":"19","author":"Al-Mutairi","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01599-17","article-title":"Role of disputed mutations in the rpoB gene in interpretation of automated liquid MGIT culture results for rifampin susceptibility testing of Mycobacterium tuberculosis","volume":"56","author":"Miotto","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jgar.2024.12.026","article-title":"Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022","volume":"41","author":"Ei","year":"2025","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.bbrc.2026.153563_bib50","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.2147\/IDR.S375869","article-title":"Characterization of genetic variants associated with rifampicin resistance level in Mycobacterium tuberculosis clinical isolates collected in Guangzhou chest hospital, China","volume":"15","author":"Hameed","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bbrc.2026.153563_bib51","series-title":"Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-endorsed Diagnostic Tests","author":"Ardizzoni","year":"2021"},{"key":"10.1016\/j.bbrc.2026.153563_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2021.102083","article-title":"Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: the phenomenon of drug resistance is complex","volume":"128","author":"Xu","year":"2021","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bbrc.2026.153563_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01885-20","article-title":"Low-level rifampin resistance and rpoB mutations in mycobacterium tuberculosis: an analysis of whole-genome sequencing and drug susceptibility test data in New York","volume":"59","author":"Shea","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib54","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2147\/IDR.S245219","article-title":"Successful treatment of a multidrug-resistant tuberculosis patient with a negative xpert MTB\/RIF test for rifampicin-resistant tuberculosis in Guizhou province of China: a case report","volume":"13","author":"Zhao","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bbrc.2026.153563_bib55","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S1473-3099(18)30496-1","article-title":"Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-Endorsed commercial tests: an observational study","volume":"18","author":"Makhado","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/0300060521997596","article-title":"rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates from rural areas of Zhejiang, China","volume":"49","author":"Zeng","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bbrc.2026.153563_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.720436","article-title":"Whole-genome sequencing to identify missed rifampicin and isoniazid resistance among tuberculosis isolates\u2014Chennai, India, 2013\u20132016","volume":"12","author":"Tamilzhalagan","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib58","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.2147\/IDR.S375869","article-title":"Characterization of genetic variants associated with rifampicin resistance level in Mycobacterium tuberculosis clinical isolates collected in Guangzhou chest hospital, China","volume":"15","author":"Hameed","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bbrc.2026.153563_bib59","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/jac\/dkq519","article-title":"Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis","volume":"66","author":"Siu","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbrc.2026.153563_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13073-020-00793-8","article-title":"Tuberculosis outbreak clone in Eswatini missed by xpert has elevated bedaquiline resistance dated to the pre-treatment era","volume":"12","author":"Beckert","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.bbrc.2026.153563_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/JCM.39.1.107-110.2001","article-title":"Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates","volume":"39","author":"Heep","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib62","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.2147\/IDR.S333433","article-title":"RpoB mutations and effects on rifampin resistance in mycobacterium tuberculosis","volume":"14","author":"Li","year":"2021","journal-title":"Infect. Drug Resist"},{"key":"10.1016\/j.bbrc.2026.153563_bib63","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41429-021-00462-x","article-title":"Rifamycin antibiotics and the mechanisms of their failure","volume":"74","author":"Adams","year":"2021","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbrc.2026.153563_bib64","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.2147\/IDR.S313717","article-title":"Rarity of rpoB mutations outside the rifampicin resistance-determining Region of Mycobacterium tuberculosis isolates from patients responding poorly to first-line tuberculosis regimens in Beijing, China: a retrospective study","volume":"14","author":"Guo","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bbrc.2026.153563_bib65","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S1473-3099(18)30496-1","article-title":"Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study","volume":"18","author":"Makhado","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib66","author":"Solari"},{"key":"10.1016\/j.bbrc.2026.153563_bib67","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1128\/JCM.00691-14","article-title":"Profiling of rpoB mutations and MICs for rifampin and rifabutin in mycobacterium tuberculosis","volume":"52","author":"Jamieson","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib68","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/JCM.01578-10","article-title":"Simultaneous identification of mycobacterial isolates to the species level and determination of tuberculosis drug resistance by PCR followed by electrospray ionization mass spectrometry","volume":"49","author":"Massire","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib69","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1128\/JCM.39.10.3736-3739.2001","article-title":"Molecular characterization of rifampin-resistant isolates of mycobactedum tuberculosis from Hungary by DNA sequencing and the line probe assay","volume":"39","author":"B\u00e1rtfai","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib70","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JCM.00330-06","article-title":"Mutations prevalent among Rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam","volume":"44","author":"Caws","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib71","author":"Li"},{"key":"10.1016\/j.bbrc.2026.153563_bib72","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4102\/ajlm.v12i1.1975","article-title":"Consequences of rpoB mutations missed by the GenoType MTBDRplus assay in a programmatic setting in South Africa","volume":"12","author":"Mvelase","year":"2023","journal-title":"Afr. J. Lab. Med."},{"key":"10.1016\/j.bbrc.2026.153563_bib73","article-title":"Whole genome sequencing for surveillance of tuberculosis drug resistance in China: based on a cross-sectional surveillance study","author":"Liu","year":"2021","journal-title":"SSRN Electron. J."},{"key":"10.1016\/j.bbrc.2026.153563_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01252-22","article-title":"Rapid identification of drug resistance and phylogeny in M. tuberculosis, directly from sputum samples","volume":"10","author":"Barbosa-Amezcua","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2026.153563_bib75","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.2147\/IDR.S386863","article-title":"rpoB mutations are associated with variable levels of rifampin and rifabutin resistance in Mycobacterium tuberculosis","volume":"15","author":"Li","year":"2022","journal-title":"Infect. Drug Resist"},{"key":"10.1016\/j.bbrc.2026.153563_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01631-23","article-title":"Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: implications for a diagnostic accuracy","volume":"12","author":"Qadir","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2026.153563_bib77","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijantimicag.2005.06.009","article-title":"The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait","volume":"26","author":"Ahmad","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bbrc.2026.153563_bib78","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1128\/AAC.49.6.2200-2209.2005","article-title":"Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis","volume":"49","author":"McCammon","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2026.153563_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01252-22","article-title":"Rapid identification of drug resistance and phylogeny in M. tuberculosis, directly from sputum samples","volume":"10","author":"Barbosa-Amezcua","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2026.153563_bib80","article-title":"Exploring programmatic indicators of tuberculosis control that incorporate routine Mycobacterium tuberculosis sequencing in low incidence settings: a comprehensive (2017\u20132021) patient cohort analysis","volume":"41","author":"Zhang","year":"2023","journal-title":"Lancet Reg. Health West. Pac"},{"key":"10.1016\/j.bbrc.2026.153563_bib81","article-title":"Novel and reported compensatory mutations in rpoABC genes found in drug resistant tuberculosis outbreaks","volume":"14","author":"Conkle-Gutierrez","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib82","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02405-23","article-title":"Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone","volume":"12","author":"Blankson","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2026.153563_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294670","article-title":"A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools","volume":"18","author":"Morey-Le\u00f3n","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153563_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210302","article-title":"Insight into population structure and drug resistance of pediatric tuberculosis strains from China and Russia gained through whole-genome sequencing","volume":"24","author":"Zhdanova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153563_bib85","first-page":"1487","article-title":"NZMJ production editor NZMA chair NZMA communications manager subscription rates for 2018","volume":"131","author":"Stewart","year":"2018","journal-title":"NZMJ"},{"key":"10.1016\/j.bbrc.2026.153563_bib86","article-title":"Exploring programmatic indicators of tuberculosis control that incorporate routine Mycobacterium tuberculosis sequencing in low incidence settings: a comprehensive (2017-2021) patient cohort analysis","volume":"41","author":"Zhang","year":"2023","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.bbrc.2026.153563_bib87","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00925-22","article-title":"First detection of Mycobacterium tuberculosis clinical isolates harboring I491F borderline resistance rpoB mutation in Myanmar","volume":"66","author":"Mon","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2026.153563_bib88","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1017\/S0950268820003131","article-title":"Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China","volume":"149","author":"Liu","year":"2021","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.bbrc.2026.153563_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00364-21","article-title":"Rifampicin-monoresistant tuberculosis is not the same as multidrug-resistant tuberculosis: a descriptive study from Khayelitsha, South Africa","volume":"65","author":"Salaam-Dreyer","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2026.153563_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2025.100925","article-title":"Lineage identification and mutation profile of mycobacterium tuberculosis: a study from national reference laboratory, India","volume":"57","author":"Yadav","year":"2025","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib91","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMc1413930","article-title":"Detection of drug-resistant tuberculosis by xpert MTB\/RIF in Swaziland","volume":"372","author":"Sanchez-Padilla","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153563_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1535160","article-title":"Whole genomic analysis uncovers high genetic diversity of rifampicin-resistant Mycobacterium tuberculosis strains in Botswana","volume":"16","author":"Mogashoa","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib93","doi-asserted-by":"crossref","unstructured":"E. Santos L\u00e1zaro, R. Gavil\u00e1n, C. Universidad, P. San, J.B. Lely, S. Zerpa, A.V. Tayro, Whole genome analysis of extensively drug resistant Mycobacterium tuberculosis strains in Peru, (n.d.). https:\/\/doi.org\/10.21203\/rs.3.rs-122146\/v1.","DOI":"10.21203\/rs.3.rs-122146\/v1"},{"key":"10.1016\/j.bbrc.2026.153563_bib94","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5588\/ijtld.11.0223","volume":"16","author":"Vincent","year":"2012","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib95","author":"Ajbani"},{"key":"10.1016\/j.bbrc.2026.153563_bib96","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/JCM.02741-12","article-title":"Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations","volume":"51","author":"Rigouts","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib97","first-page":"93","article-title":"Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in Punjab, Pakistan","volume":"45","author":"Khan","year":"2013","journal-title":"Pakistan J. Zool."},{"key":"10.1016\/j.bbrc.2026.153563_bib98","doi-asserted-by":"crossref","first-page":"23","DOI":"10.33073\/pjm-2012-003","article-title":"Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria","volume":"61","author":"Madania","year":"2012","journal-title":"Pol. J. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02265","article-title":"Evaluation of genotype MTBDRplus and MTBDRsl assays for rapid detection of drug resistance in extensively drug-resistant Mycobacterium tuberculosis isolates in Pakistan","volume":"9","author":"Javed","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib100","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-0463.2009.02438.x","article-title":"Drug resistance and genotypic analysis of Mycobacterium tuberculosis strains from Thai tuberculosis patients","volume":"117","author":"Cheunoy","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.bbrc.2026.153563_bib101","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-3156.2010.02697.x","volume":"16","author":"Ereqat","year":"2011","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.bbrc.2026.153563_bib102","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.meegid.2016.02.019","article-title":"Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda","volume":"40","author":"Ssengooba","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.bbrc.2026.153563_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2002.00478.x","article-title":"Antimicrobial susceptibility testing of Mycobacterium tuberculosis","volume":"8","author":"Dorbniewski","year":"2002","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.bbrc.2026.153563_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.870768","article-title":"Tuberculosis phenotypic and genotypic drug susceptibility testing and immunodiagnostics: a review","volume":"13","author":"Yusoof","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153563_bib106","unstructured":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis, (n.d.). https:\/\/www.who.int\/publications\/i\/item\/9789241514842 (accessed September 27, 2025)."},{"key":"10.1016\/j.bbrc.2026.153563_bib104","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/antibiotics14070732","article-title":"Genotypic and phenotypic methods in the detection of MDR-TB and evolution to XDR-TB","volume":"14","author":"Zaporojan","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.bbrc.2026.153563_bib107","doi-asserted-by":"crossref","first-page":"277","DOI":"10.12701\/yujm.2020.00626","article-title":"Diagnosis and treatment of multidrug-resistant tuberculosis","volume":"37","author":"Jang","year":"2020","journal-title":"Yeungnam Univ. J. Med."},{"key":"10.1016\/j.bbrc.2026.153563_bib109","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1128\/JCM.37.8.2663-2666.1999","article-title":"Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay","volume":"37","author":"Hirano","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmi.2016.09.006","article-title":"Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria","volume":"23","author":"Andre","year":"2017","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.bbrc.2026.153563_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277145","article-title":"High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB\/RIF assay positive pulmonary tuberculosis cases, in addis Ababa, Ethiopia","volume":"17","author":"Akalu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153563_bib111","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf132","article-title":"Limitations of the MTB\/RIF assay: an xpert review of 4 clinical cases","volume":"12","author":"Haas","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-020-00793-8","article-title":"Tuberculosis outbreak clone in Eswatini missed by xpert has elevated bedaquiline resistance dated to the pre-treatment era","volume":"12","author":"Beckert","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.bbrc.2026.153563_bib113","unstructured":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, (n.d.). https:\/\/www.who.int\/publications\/i\/item\/9789240028173 (accessed September 30, 2025)."},{"key":"10.1016\/j.bbrc.2026.153563_bib114","unstructured":"Use of targeted next-generation sequencingto detect drug-resistant tuberculosis, (n.d.). https:\/\/www.who.int\/publications\/i\/item\/9789240076372 (accessed September 30, 2025)."},{"key":"10.1016\/j.bbrc.2026.153563_bib117","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/microorganisms13092163","article-title":"Characterization of drug resistance mutations in Mycobacterium tuberculosis isolates from Moroccan patients using deeplex targeted next-generation sequencing","volume":"13","author":"Laatri","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.bbrc.2026.153563_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120520","article-title":"Application of next-generation sequencing in the detection of antimicrobial resistance","volume":"578","author":"Wang","year":"2026","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2026.153563_bib118","unstructured":"Deeplex Myc-TB - Mycobacterium tuberculosis Drug Resistance Prediction Assay, (n.d.). https:\/\/www.genoscreen.fr\/en\/genomic-services\/products\/deeplex-myc-tb (accessed September 30, 2025)."},{"key":"10.1016\/j.bbrc.2026.153563_bib119","first-page":"1","article-title":"Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing","volume":"14","author":"Sibandze","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.bbrc.2026.153563_bib120","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.47.7.2231-2235.2003","article-title":"Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears","volume":"47","author":"Mokrousov","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2026.153563_bib121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mcp.2009.08.001","article-title":"Enhancing allele-specific PCR for specifically detecting short deletion and insertion DNA mutations","volume":"24","author":"Wang","year":"2010","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.bbrc.2026.153563_bib122","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1046-2023(05)80124-0","article-title":"Allele-specific polymerase chain reaction","volume":"2","author":"Ugozzoli","year":"1991","journal-title":"Methods"},{"key":"10.1016\/j.bbrc.2026.153563_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.707244","article-title":"A comprehensive evaluation of GeneLEAD VIII DNA platform combined to deeplex Myc-TB\u00ae assay to detect in 8 days drug resistance to 13 antituberculous drugs and transmission of Mycobacterium tuberculosis complex directly from clinical samples","volume":"11","author":"Bonnet","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib123","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jiph.2015.05.003","article-title":"Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India","volume":"8","author":"Thirumurugan","year":"2015","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.bbrc.2026.153563_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253235","article-title":"Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection","volume":"16","author":"Singpanomchai","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153563_bib125","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S1473-3099(18)30496-1","article-title":"Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study","volume":"18","author":"Makhado","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib126","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-0446-4_5","article-title":"Genotyping by high-resolution melting analysis","volume":"1145","author":"Tucker","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153563_bib127","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-0716-3024-2_24","article-title":"High-resolution melting (HRM) genotyping","volume":"2638","author":"Kim","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153563_bib128","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s10156-013-0636-3","article-title":"High resolution melting curve assay for rapid detection of drug-resistant Mycobacterium tuberculosis","volume":"19","author":"Nagai","year":"2013","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.bbrc.2026.153563_bib129","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s12879-017-2666-4","article-title":"Plasmid-based high-resolution melting analysis for accurate detection of rpoB mutations in Mycobacterium tuberculosis isolates from Moroccan patients","volume":"17","author":"Bentaleb","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib130","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/JCM.02036-09","article-title":"Rapid detection of Rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis","volume":"48","author":"Ong","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib131","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1128\/JCM.02104-16","article-title":"Direct detection of rifampin and isoniazid resistance in sputum samples from tuberculosis patients by high-resolution melt curve analysis","volume":"55","author":"Anthwal","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib132","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4103\/ijmy.ijmy_100_18","article-title":"Effective pragmatic approach of diagnosis of multidrug-resistant tuberculosis by high-resolution melt curve assay","volume":"7","author":"Negi","year":"2018","journal-title":"Int. J. Mycobacteriol."},{"key":"10.1016\/j.bbrc.2026.153563_bib133","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1128\/JCM.01264-13","article-title":"High-resolution melting curve analysis for rapid detection of rifampin resistance in mycobacterium tuberculosis: a meta-analysis","volume":"51","author":"Yin","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib134","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/JCM.01068-11","article-title":"Rapid detection of isoniazid, rifampin, and ofloxacin resistance in mycobacterium tuberculosis clinical isolates using high-resolution melting analysis","volume":"49","author":"Chen","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib135","doi-asserted-by":"crossref","first-page":"267.e5","DOI":"10.1016\/j.cmi.2016.12.009","article-title":"Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays","volume":"23","author":"Andr\u00e9","year":"2017","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.bbrc.2026.153563_bib136","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s15010-024-02295-w","article-title":"Accurate and affordable detection of rifampicin and isoniazid resistance in tuberculosis sputum specimens by multiplex PCR-multiple probes melting analysis","volume":"52","author":"Xie","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.bbrc.2026.153563_bib137","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1021\/acsinfecdis.5c00150","article-title":"Single-sample melt-based screening for rifampicin susceptibility in the emerging mutation hotspot at rpoB codon 491","volume":"11","author":"Malofsky","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib143","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf121","article-title":"Rapid diagnostic sequencing of stool DNA using targeted nanopore sequencing in patients with a pulmonary tuberculosis diagnosis","volume":"12","author":"Ness","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib138","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s41587-021-01108-x","article-title":"Nanopore sequencing technology, bioinformatics and applications","volume":"39","author":"Wang","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.153563_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-025-03747-1","article-title":"An exploratory study on the application of nanopore sequencing for detecting Mycobacterium tuberculosis drug resistance in respiratory specimens","volume":"25","author":"Wei","year":"2025","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bbrc.2026.153563_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1331656","article-title":"High-throughput nanopore targeted sequencing for efficient drug resistance assay of Mycobacterium tuberculosis","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib141","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1186\/s12879-025-11227-4","article-title":"Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib142","article-title":"Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153563_bib144","unstructured":"WHO announces first prequalification of a tuberculosis diagnostic test, (n.d.). https:\/\/www.who.int\/news\/item\/05-12-2024-who-announces-first-prequalification-of-a-tuberculosis-diagnostic-test?utm_source=chatgpt.com (accessed February 15, 2026)."},{"key":"10.1016\/j.bbrc.2026.153563_bib145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/antibiotics13080786","article-title":"Rapid phenotypic and genotypic antimicrobial susceptibility testing approaches for use in the clinical laboratory","volume":"13","author":"Hattab","year":"2024","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153563_bib146","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-025-59736-9","article-title":"Phenotypic drug susceptibility testing for Mycobacterium tuberculosis variant bovis BCG in 12 hours","volume":"16","author":"Tran","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153563_bib147","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s40588-022-00183-1","article-title":"MinION whole-genome sequencing in resource-limited settings: challenges and opportunities","volume":"9","author":"Wasswa","year":"2022","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"10.1016\/j.bbrc.2026.153563_bib148","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ijtb.2025.06.007","article-title":"Evaluation of multiplex allele-specific PCR for rapid detection of isoniazid and fluoroquinolone resistance in mycobacterium tuberculosis: a cross-sectional study in high-TB-burden settings in India","volume":"72","author":"Kaushik","year":"2025","journal-title":"Indian J. Tubercul."},{"key":"10.1016\/j.bbrc.2026.153563_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1206056","article-title":"Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing","volume":"11","author":"Murphy","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bbrc.2026.153563_bib150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4046\/trd.2021.0134","article-title":"A rapid assessing method of drug susceptibility using flow cytometry for Mycobacterium tuberculosis isolates resistant to isoniazid, rifampin, and ethambutol","volume":"85","author":"Lee","year":"2022","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib151","article-title":"Discordance between genotypic and phenotypic methods for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis and the correlation with patient treatment outcomes","volume":"34","author":"Bonsa","year":"2023","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib152","first-page":"429","article-title":"Investigation of the rpoB mutations causing rifampin resistance by rapid screening in Mycobacterium tuberculosis in North-East of Iran, Iran","volume":"13","author":"Tajbakhsh","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbrc.2026.153563_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06708-1","article-title":"High resolution melting assay as a reliable method for diagnosing drug-resistant TB cases: a systematic review and meta-analysis","volume":"21","author":"Keikha","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.153563_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257521","article-title":"Sequencing DNA with nanopores: troubles and biases","volume":"16","author":"Delahaye","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153563_bib155","unstructured":"Global Strategy and Targets for Tuberculosis Prevention, Care and Control After 2015 Report by the Secretariat, (n.d.)."},{"key":"10.1016\/j.bbrc.2026.153563_bib156","article-title":"Implementing molecular tuberculosis diagnostic methods in limited-resource and high-burden countries","volume":"18","author":"Vasiliu","year":"2023","journal-title":"Breathe"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2600327X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2600327X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:11:06Z","timestamp":1774926666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2600327X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":156,"alternative-id":["S0006291X2600327X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153563","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding antibiotic resistance in tuberculosis: Role of RRDR and non-RRDR mutations in diagnostic perspectives","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153563"}}